Immune-Oncology Archives · BioBuzz

Emerging T Cell Therapy Company NexImmune Receives First IND Clearance for Phase 1/2 Trial in Acute Myeloid Leukemia / Myelodysplastic Syndrome

<img width="300" height="91" src="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/10/Neximmune-trans-300x91.png?lossy=1&strip=1&webp=1" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image" alt="" decoding="async" srcset="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/10/Neximmune-trans.png?size=60x18&lossy=1&strip=1&webp=1 60w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/10/Neximmune-trans.png?size=120x36&lossy=1&strip=1&webp=1 120w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/10/Neximmune-trans.png?size=180x55&lossy=1&strip=1&webp=1 180w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/10/Neximmune-trans.png?size=240x73&lossy=1&strip=1&webp=1 240w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/10/Neximmune-trans-300x91.png?lossy=1&strip=1&webp=1 300w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : October 31, 2019September 26, 2020 Published by : Chris Frew

Emerging T Cell Therapy Company NexImmune Receives First IND Clearance for Phase 1/2 Trial in Acute Myeloid Leukemia / Myelodysplastic Syndrome October 31, 2019 07:30 ET | Source: NexImmune, Inc. IND clearance enables [….]

Immune-oncology Leaders Converge on Montgomery College for Bio-Trac’s Multiplex Immunofluorescence Symposium

<img width="300" height="300" src="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/09/cropped-BioscienceEducationCenter-300x300.jpg?lossy=1&strip=1&webp=1" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image" alt="" decoding="async" loading="lazy" srcset="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/09/cropped-BioscienceEducationCenter-75x75.jpg?lossy=1&strip=1&webp=1 75w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/09/cropped-BioscienceEducationCenter-100x100.jpg?lossy=1&strip=1&webp=1 100w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/09/cropped-BioscienceEducationCenter-150x150.jpg?lossy=1&strip=1&webp=1 150w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/09/cropped-BioscienceEducationCenter.jpg?size=240x240&lossy=1&strip=1&webp=1 240w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/09/cropped-BioscienceEducationCenter-300x300.jpg?lossy=1&strip=1&webp=1 300w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : September 17, 2019September 24, 2019 Published by : Steven Surdez

Immune-oncology Leaders Converge on Montgomery College for Bio-Trac’s Multiplex Immunofluorescence Symposium

Local Entrepreneur Brings Swedish Company AcouSort to BioHealth Capital Region

<img width="300" height="300" src="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/02/GIC-300x300.png?lossy=1&strip=1&webp=1" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image" alt="" decoding="async" loading="lazy" srcset="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/02/GIC-75x75.png?lossy=1&strip=1&webp=1 75w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/02/GIC-100x100.png?lossy=1&strip=1&webp=1 100w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/02/GIC-150x150.png?lossy=1&strip=1&webp=1 150w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/02/GIC.png?size=240x240&lossy=1&strip=1&webp=1 240w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2019/02/GIC-300x300.png?lossy=1&strip=1&webp=1 300w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : February 26, 2019February 28, 2019 Published by : Steven Surdez

Local Entrepreneur Brings Swedish Company AcouSort to BioHealth Capital Region February 26, 2019 For every AstraZeneca, there are hundreds of small biotech startups and scores of life science innovators that [….]

Q&A with Jaime Rodriguez-Canales, M.D., FEBP – The importance of Multiplex Immunofluorescence in the field of Immune-Oncology

<img width="300" height="300" src="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/10/Jaime-Rodriguez-Canales-M.D.-FEBP-300x300.png?lossy=1&strip=1&webp=1" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image" alt="" decoding="async" loading="lazy" srcset="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/10/Jaime-Rodriguez-Canales-M.D.-FEBP-75x75.png?lossy=1&strip=1&webp=1 75w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/10/Jaime-Rodriguez-Canales-M.D.-FEBP-100x100.png?lossy=1&strip=1&webp=1 100w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/10/Jaime-Rodriguez-Canales-M.D.-FEBP-150x150.png?lossy=1&strip=1&webp=1 150w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/10/Jaime-Rodriguez-Canales-M.D.-FEBP.png?size=240x240&lossy=1&strip=1&webp=1 240w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/10/Jaime-Rodriguez-Canales-M.D.-FEBP-300x300.png?lossy=1&strip=1&webp=1 300w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : October 30, 2018September 20, 2021 Published by : Chris Frew

Q&A with Jaime Rodriguez-Canales, M.D., FEBP Dr. Rodriguez-Canales is a Senior Pathologist at MedImmune, and Course Director for the recent Multiplex Immunofluorescence in Immune-Oncology Symposium, a Bio-Trac program cosponsored by [….]

New Technology Impacting Immune-Oncology Research Attracts National Audience at First Annual Bio-Trac Symposium

<img width="300" height="300" src="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/10/IMG_2595-300x300.jpg?lossy=1&strip=1&webp=1" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image" alt="" decoding="async" loading="lazy" srcset="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/10/IMG_2595-scaled-75x75.jpg?lossy=1&strip=1&webp=1 75w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/10/IMG_2595-100x100.jpg?lossy=1&strip=1&webp=1 100w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/10/IMG_2595-150x150.jpg?lossy=1&strip=1&webp=1 150w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/10/IMG_2595.jpg?size=240x240&lossy=1&strip=1&webp=1 240w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/10/IMG_2595-300x300.jpg?lossy=1&strip=1&webp=1 300w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : October 3, 2018July 19, 2019 Published by : Gina Hagler

Immune-Oncology Symposium